Pharma News - Chemdiv

Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Today, privately held Navitor Pharmaceuticals, LLC, announced that Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson has acquired Anakuria Therapeu...

GSK to get $1.25 bln to settle HIV drug patent row with Gilead

Britain's GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines unit and the U.S.-based drugmaker, ending a long-drawn patent d...

FDA places partial clinical hold on umbralisib and ublituximab trials in CLL and NHL

The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on a series of trials investigating the use using umbralisib in combination with ublituximab (U2) as a treatment for c...

Timber Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis

Timber Pharmaceuticals announced the successful completion of an End-of-Phase 2 meeting with the U.S. FDA resulting in a clear path towards a pivotal Phase 3 study for its lead asset, TMB-001, a to...

Researchers develop new approach to discover pervasive ‘forever’ chemicals known as PFAS

PFAS, a family of thousands of human-made chemicals, are everywhere, and some of them are known to be harmful for our bodies and the environment.

FDA Approves First Generic of Restasis for Dry Eye

The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions of Americans each year.

A pill that releases RNA in the stomach could offer a new way to administer vaccines

Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles.

FDA Approves Glenmark Pharmaceuticals’ Generic Metronidazole Gel

Glenmark Pharmaceuticals USA has received FDA’s approval for its generic version of MetroGel-Vaginal Gel (metronidazole) 0.75 percent made by Bausch Health.

ImmunityBio announces positive study results for ‘Kick and Kill’ HIV cure strategy to reduce HIV viral load with Anktiva therapy

ImmunityBio, Inc., a clinical-stage immunotherapy company, announced promising study results that demonstrate the activation of CD4+ and CD8+ T cells and natural killer (NK) cells in people living ...

Oxford Biomedica, Homology Medicines to create AAV manufacturing JV in US

Oxford Biomedica, a UK-based gene and cell therapy company, has agreed to form a joint venture (JV) to undertake an adeno-associated virus (AAV) manufacturing and innovation business in the US with...

Lilly to build $1bn manufacturing plant in Concord, North Carolina

Eli Lilly and Company (Lilly) said that it will invest more than $1 billion to build a new manufacturing plant in Concord, North Carolina.

Pfizer and Ionis End Vupanorsen Program for Heart Disease

After disappointing phase 2 results, Pfizer and Ionis Pharmaceuticals have scrapped their development program for vupanorsen for heart disease and severe hyperglyceridemia indications. ...